NCT03011775View on ClinicalTrials.gov

Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

September 30, 2015

Conditions
Adverse EffectAtherosclerosis, CoronaryInsulin Resistance Syndrome
Interventions
DRUG

Pioglitazone 15 mg Tablet

Pioglar (Ranbaxy India):1 tablet per day in the morning for 6 months

DRUG

Isosorbide Dinitrate 10Mg Tablet

1-2 tablets 2 times a day

DRUG

Acetylsalicylic Acid 75Mg Tablet

1 tablet per a day

DRUG

Bisoprolol Fumarate 2.5 MG Oral Tablet

1 tablet per a day

DRUG

Rosuvastatin Calcium 20 MG Oral Tablet

1 tablet per a day

DRUG

Ramipril 5 MG

1 tablet per a day

Trial Locations (1)

36011

Ukrainian Medical Stomatological Academy, Poltava

All Listed Sponsors
lead

Ukrainian Medical Stomatological Academy

OTHER

NCT03011775 - Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease | Biotech Hunter | Biotech Hunter